Answers are grounded in this paper and cite their sources.
Haploinsufficiency of A20 (HA20) is a rare autoinflammatory disorder caused by heterozygous loss‐of‐function variants in tumor necrosis factor alpha‐induced protein 3 ( TNFAIP3 ), encoding a negative regulator of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NFκB) signaling. We report two pediatric patients with a previously unreported novel pathogenic variant (p. Glu409*) in the zinc finger (ZnF) 1 domain, exhibiting markedly divergent phenotypes. Case 1 presented with very‐early‐onset inflammatory bowel disease (VEO‐IBD) and autoimmune thyroiditis, requiring aggressive infliximab dose escalation. Case 2 developed fulminant hepatic failure requiring liver transplantation, followed by post‐transplant complications including refractory rejection, recurrent infections, and post‐transplant lymphoproliferative disorder. This represents the first known case of HA20 in solid organ transplantation. These cases underscore the importance of early genetic diagnosis in unexplained pediatric inflammatory disease and transplant rejection, as HA20 recognition may alter immunosuppressive strategies and guide therapies including cytokine blockade or Janus kinase (JAK) inhibition.
No takes yet. Share an insight, caveat, or question.
Blake et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: